InvestorsHub Logo
Followers 29
Posts 3997
Boards Moderated 0
Alias Born 10/16/2003

Re: blackcat post# 961

Wednesday, 05/18/2016 11:34:55 PM

Wednesday, May 18, 2016 11:34:55 PM

Post# of 1231
Over a year ago???

The info at clinicaltrials.gov and verified by Ziopharm in February of 2016 has the study start date in June of 2016, that's 11 months ago....and they've only dosed 11 patients, one of whom died but the PR doesn't say when. And we don't know when the first patient was dosed, the PR doesn't say that either....so maybe the first patient was dosed 7 months ago, in the absence of information all one can do is speculate.

But the trial is meeting its primary objective of safety, so that at least is positive. As for survival rates, the collection of data will help determine to what extent Veledimex is responsible and what if any impact Ads-RTS-hIL-12 is having.....

You can't draw cause and effect conclusions from such thin data....although clearly that is what is happening with a lot of people, and maybe that was the intent of the PR.

Like those ads that say: In a recent government survey 9 out of 10 doctors reccommend....

Those type of statements get the attention of the trailer park crowd, but intelligent people ask questions.

1- How recent? Last year, 5 years ago? 10?
2- What government? The Grand Dutchee of Fenwick?
3) Doctors of what? Divinity?

If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRT News